Aveanna Healthcare (NASDAQ:AVAH) Price Target Lowered to $9.00 at Royal Bank Of Canada

Aveanna Healthcare (NASDAQ:AVAH) had its price objective lowered by Royal Bank Of Canada from $11.00 to $9.00 in a research report report published on Monday morning,Benzinga reports. The brokerage currently has a sector perform rating on the stock.

A number of other research analysts have also recently issued reports on AVAH. William Blair assumed coverage on shares of Aveanna Healthcare in a report on Monday, December 8th. They issued an “outperform” rating for the company. BMO Capital Markets decreased their price target on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research note on Friday. Raymond James Financial upgraded Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target on the stock in a report on Friday. UBS Group raised their price objective on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, January 15th. Finally, Weiss Ratings raised Aveanna Healthcare from a “hold (c)” rating to a “buy (b-)” rating in a report on Friday. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Aveanna Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $10.56.

Aveanna Healthcare Stock Up 2.9%

Aveanna Healthcare stock opened at $6.71 on Monday. The company has a debt-to-equity ratio of 6.62, a current ratio of 1.32 and a quick ratio of 1.32. Aveanna Healthcare has a 1-year low of $3.73 and a 1-year high of $10.32. The company has a market cap of $1.46 billion, a PE ratio of 6.58 and a beta of 2.07. The stock’s 50 day moving average price is $7.80 and its 200 day moving average price is $8.49.

Insider Activity at Aveanna Healthcare

In related news, insider Edwin C. Reisz sold 60,769 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $438,144.49. Following the transaction, the insider owned 1,447,057 shares of the company’s stock, valued at approximately $10,433,280.97. This represents a 4.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Jeff Shaner sold 173,225 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $1,248,952.25. Following the sale, the chief executive officer owned 2,650,892 shares in the company, valued at approximately $19,112,931.32. This trade represents a 6.13% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 998,595 shares of company stock worth $7,567,770 over the last three months. Company insiders own 7.00% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Dynamic Technology Lab Private Ltd boosted its holdings in Aveanna Healthcare by 8.9% in the third quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after acquiring an additional 1,151 shares during the last quarter. Barclays PLC increased its stake in Aveanna Healthcare by 0.8% during the third quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after acquiring an additional 1,366 shares during the last quarter. Franklin Resources Inc. raised its holdings in shares of Aveanna Healthcare by 4.5% in the 3rd quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock worth $316,000 after purchasing an additional 1,528 shares during the period. Intech Investment Management LLC lifted its stake in shares of Aveanna Healthcare by 9.8% in the 4th quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock valued at $159,000 after purchasing an additional 1,739 shares in the last quarter. Finally, Balboa Wealth Partners lifted its stake in shares of Aveanna Healthcare by 13.5% in the 4th quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock valued at $138,000 after purchasing an additional 2,007 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.